This post is presented by our media partner Grow Opportunity
View the full article here.
(CNW) Edmonton – Aurora Cannabis Inc., the Canadian-based leading global medical cannabis company, announces developments in cannabis science from Aurora’s world class research and genetics facility, Aurora Coast. With a continued focus on premium, science-driven insights, these latest innovations demonstrate Aurora’s commitment to providing patients with ongoing access to superior product offerings on AuroraMedical.com.
“As a company committed to leading the way in terms of cannabis innovation, we are dedicated to putting patients first by harnessing the innovative solutions developed by our top researchers at Aurora Coast, our unique global research facility,” said Lana Culley, Vice President, Science & Innovation at Aurora. “We strive to continuously raise the bar on product superiority and overall user experience so that we can deliver on our mission of providing patients with access to the very best medical cannabis.”
The latest innovations include:
- Aurora | CBD Varius (1g, 510 Cartridge); a smooth and refined option for patients.
- MedReleaf (Strains For Heroes) | Esprit De Corps (5g and 15g); a premium sativa (THC: 20-29%, CBD: 0-1%), developed under the Strains For Heroes initiative by Aurora with direct feedback from Veteran patients.
- MedReleaf | Sedamen (1g, 510 Cartridge); a patient-favourite in a higher THC, larger format.
- MedReleaf | Noculus (5g and 15g); an ultra-high potency indica, boasting THC levels between 25-31% and CBD content from 0-1%.
- WMMC | Seasonal Stash – Frosted Alpine (10g); a limited grown hybrid strain (THC: 24-30%; CBD: 0-1%).
Aurora’s world class research and development facility, Aurora Coast, located in Comox, Vancouver Island, is home to some of the most advanced cannabis research and genetics discovery work worldwide. New cultivars developed at Aurora Coast are subsequently grown across Aurora’s Canadian cultivation network where the company adheres to the highest production practices at its EU-GMP and TGA -GMP certified facilities. Aurora partners with several other licensed producers who have licenses to grow its cultivars creating more value for both Aurora and the broader industry.
Advertisement
Aurora’s industry-leading portfolio of medical cannabis products is available online via Aurora’s comprehensive medical patient platform at AuroraMedical.com. Patients can access a wide range of innovative, high-quality products tailored to meet their needs.
This post was originally published by our media partner here.